These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21498425)

  • 1. Variability of effluent cancer antigen 125 and interleukin-6 determination in peritoneal dialysis patients.
    Lopes Barreto D; Coester AM; Noordzij M; Smit W; Struijk DG; Rogers S; de Waart DR; Krediet RT
    Nephrol Dial Transplant; 2011 Nov; 26(11):3739-44. PubMed ID: 21498425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of systemic and local peritoneal inflammation on peritoneal solute transport rate in new peritoneal dialysis patients: a 1-year prospective study.
    Cho JH; Hur IK; Kim CD; Park SH; Ryu HM; Yook JM; Choi JY; Choi HJ; Choi HJ; Park JW; Do JY; Kim YL
    Nephrol Dial Transplant; 2010 Jun; 25(6):1964-73. PubMed ID: 20100731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin-6: relationship with peritoneal transport.
    Rodrigues A; Martins M; Santos MJ; Fonseca I; Oliveira JC; Cabrita A; Melo e Castro J; Krediet RT
    Adv Perit Dial; 2004; 20():8-12. PubMed ID: 15384786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do interleukin-6, hyaluronan, soluble intercellular adhesion molecule-1 and cancer antigen 125 in dialysate predict changes in peritoneal function? A 1-year follow-up study.
    Martikainen T; Ekstrand A; Honkanen E; Teppo AM; Grönhagen-Riska C
    Scand J Urol Nephrol; 2005; 39(5):410-6. PubMed ID: 16257844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
    Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
    Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers of peritoneal mesothelial cells during treatment with peritoneal dialysis.
    Ho-dac-Pannekeet MM; Hiralall JK; Struijk DG; Krediet RT
    Adv Perit Dial; 1997; 13():17-22. PubMed ID: 9360644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Icodextrin and Glucose Bicarbonate/Lactate-Buffered Peritoneal Dialysis Fluids on Effluent Cell Population and Biocompatibility Markers IL-6 and CA125 in Incident Peritoneal Dialysis Patients.
    Opatrná S; Pöpperlová A; Lysák D; Fuchsová R; Trefil L; Racek J; Topolčan O
    Ther Apher Dial; 2016 Apr; 20(2):149-57. PubMed ID: 26929256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of pH-neutral peritoneal dialysis solution.
    Moriishi M; Kawanishi H; Kawai T; Takahashi S; Hirai T; Shishida M; Watanabe H; Takahashi N
    Adv Perit Dial; 2002; 18():68-71. PubMed ID: 12402590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal kinetics of cancer antigen 125 in peritoneal dialysis patients: the relationship with peritoneal outcome.
    Jiménez C; Díaz C; Selgas R; Auxiliadora Bajo M; del Peso G; Sánchez-Tomero JA; Gonzalez-Gancedo P
    Adv Perit Dial; 1999; 15():36-9. PubMed ID: 10682069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal dialysate effluent and serum CA125 concentrations in stable peritoneal dialysis patients.
    Redahan L; Davenport A
    J Nephrol; 2016 Jun; 29(3):427-434. PubMed ID: 26616639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of dwell time on dialysate cancer antigen 125 appearance rates in patients on continuous ambulatory peritoneal dialysis.
    Akman S; van Westrhenen R; De Waart DR; Hiralall JK; Zweers MM; Krediet RT
    Adv Perit Dial; 2003; 19():24-7. PubMed ID: 14763029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of cancer antigen 125 and interleukin-15 in relation to the nutrition status of peritoneal dialysis patients.
    Grzegorzewska AE; Mlot M; Leande M
    Adv Perit Dial; 2004; 20():185-9. PubMed ID: 15384823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of dialysis duration, peritoneal transport parameters, and gender on effluent CA125 concentration in patients on peritoneal dialysis.
    Mojahedi MJ; Hami M; Shakeri MT; Hekmat R
    Iran J Kidney Dis; 2007 Oct; 1(2):78-81. PubMed ID: 19363281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients.
    Oh KH; Jung JY; Yoon MO; Song A; Lee H; Ro H; Hwang YH; Kim DK; Margetts P; Ahn C
    Nephrol Dial Transplant; 2010 May; 25(5):1639-46. PubMed ID: 20061317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of aldose reductase in the peritoneal changes of patients undergoing peritoneal dialysis.
    Hasuike Y; Moriguchi R; Hata R; Miyagawa K; Kuragano T; Aizawa M; Yamamoto S; Yanase K; Izumi M; Tanimoto T; Nakanishi T
    Am J Nephrol; 2007; 27(6):622-9. PubMed ID: 17851230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products--a 1-year randomized control trial.
    Szeto CC; Chow KM; Lam CW; Leung CB; Kwan BC; Chung KY; Law MC; Li PK
    Nephrol Dial Transplant; 2007 Feb; 22(2):552-9. PubMed ID: 17005526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necessity of correcting cancer antigen 125 appearance rates by body surface area.
    Kawanishi H; Moriishi M; Harada Y; Sakikubo E; Nagai T; Tsuchiya S
    Adv Perit Dial; 2000; 16():22-5. PubMed ID: 11045255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic role of peritoneal CA 125 in peritoneal dialysis patients presenting with acute peritonitis.
    Panorchan K; Davenport A
    BMC Nephrol; 2014 Sep; 15():149. PubMed ID: 25217152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal follow-up of CA125 in peritoneal effluent.
    Ho-dac-Pannekeet MM; Hiralall JK; Struijk DG; Krediet RT
    Kidney Int; 1997 Mar; 51(3):888-93. PubMed ID: 9067926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.